Connect Biopharma (CNTB) Short Interest Ratio & Short Volume → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free CNTB Stock Alerts $1.94 +0.49 (+33.79%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Connect Biopharma Short Interest DataCurrent Short Volume31,200 sharesPrevious Short Volume83,100 sharesChange Vs. Previous Month-62.45%Dollar Volume Sold Short$43,368.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 30, 2024Outstanding Shares55,100,000 sharesFloat Size53,110,000 sharesShort Percent of Float0.06%Today's Trading Volume330,245 sharesAverage Trading Volume136,091 sharesToday's Volume Vs. Average243% Short Selling Connect Biopharma ? Sign up to receive the latest short interest report for Connect Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCNTB Short Interest Over TimeCNTB Days to Cover Over TimeCNTB Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Connect Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202431,200 shares $43,368.00 -62.5%0.1%0.2 $1.39 4/15/202483,100 shares $138,777.00 -28.1%0.2%0.5 $1.67 3/31/2024115,500 shares $200,970.00 +7.5%0.2%0.7 $1.74 3/15/2024107,400 shares $139,620.00 -13.2%0.2%0.8 $1.30 2/29/2024123,700 shares $141,018.00 -2.7%0.2%0.4 $1.14 2/15/2024127,100 shares $153,791.00 -34.8%0.2%0.4 $1.21 Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024194,800 shares $227,916.00 +52.8%0.4%0.5 $1.17 1/15/2024127,500 shares $140,862.00 -21.3%0.2%0.3 $1.10 12/31/2023162,100 shares $191,278.00 -59.8%0.3%0.4 $1.18 12/15/2023403,200 shares $380,540.16 +208.3%0.8%1.1 $0.94 11/30/2023130,800 shares $150,420.00 +476.2%0.3%0.6 $1.15 11/15/202322,700 shares $40,406.00 -22.8%0.0%0.1 $1.78 10/31/202329,400 shares $43,218.00 +88.5%0.1%0.5 $1.47 10/15/202315,600 shares $13,543.92 -40.7%0.0%0.3 $0.87 9/30/202326,300 shares $21,539.70 +250.7%0.1%0.6 $0.82 9/15/20237,500 shares $5,700.75 -13.8%0.0%0.2 $0.76 8/31/20238,700 shares $7,184.46 -61.5%0.0%0.2 $0.83 8/15/202322,600 shares $20,358.08 -48.3%0.0%0.1 $0.90 7/31/202343,700 shares $42,389.00 +55.5%0.1%0.1 $0.97 7/15/202328,100 shares $30,348.00 -52.5%0.1%0.1 $1.08 6/30/202359,200 shares $66,896.00 -19.8%0.1%0.2 $1.13 6/15/202373,800 shares $74,538.00 -12.3%0.1%0.2 $1.01 5/31/202384,100 shares $91,147.58 +14.3%0.2%0.1 $1.08 5/15/202373,600 shares $91,256.64 -23.1%0.1%0.2 $1.24 4/30/202395,700 shares $101,920.50 -25.8%0.2%0.3 $1.07 4/15/2023128,900 shares $135,345.00 -14.1%0.2%0.4 $1.05 3/31/2023150,000 shares $149,985.00 +100.8%0.3%0.5 $1.00 3/15/202374,700 shares $83,664.00 -12.2%0.1%0.2 $1.12 2/28/202385,100 shares $109,779.00 -15.0%0.2%1.6 $1.29 2/15/2023100,100 shares $103,103.00 -11.0%0.2%2 $1.03 1/31/2023112,500 shares $138,375.00 -3.5%0.2%2.3 $1.23 1/15/2023116,600 shares $115,317.40 -12.5%0.2%2.3 $0.99 12/30/2022133,200 shares $115,590.96 -58.0%0.3%2.4 $0.87 12/15/2022316,800 shares $275,616.00 -1.2%0.6%2.8 $0.87 11/30/2022320,600 shares $232,531.18 -4.0%0.6%2.8 $0.73 11/15/2022334,000 shares $251,201.40 -8.2%0.6%2.5 $0.75 10/31/2022364,000 shares $316,607.20 -32.0%0.7%2.1 $0.87 10/15/2022535,000 shares $506,003.00 +29.9%1.0%1.7 $0.95 9/30/2022411,900 shares $531,351.00 +2.6%0.8%1.3 $1.29 9/15/2022401,400 shares $586,044.00 -15.7%0.8%1.1 $1.46How to Make 100X on the AI Boom (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs CNTB Short Interest - Frequently Asked Questions What is Connect Biopharma's current short interest? Short interest is the volume of Connect Biopharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 31,200 shares of CNTB short. 0.06% of Connect Biopharma's shares are currently sold short. Learn More on Connect Biopharma's current short interest. Which institutional investors are shorting Connect Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Connect Biopharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Connect Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.06% of Connect Biopharma's floating shares are currently sold short. Is Connect Biopharma's short interest increasing or decreasing? Connect Biopharma saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 31,200 shares, a drop of 62.5% from the previous total of 83,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Connect Biopharma's float size? Connect Biopharma currently has issued a total of 55,100,000 shares. Some of Connect Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Connect Biopharma currently has a public float of 53,110,000 shares. How does Connect Biopharma's short interest compare to its competitors? 0.06% of Connect Biopharma's shares are currently sold short. Here is how the short interest of companies compare to Connect Biopharma: Corvus Pharmaceuticals, Inc. (3.69%), Jaguar Health, Inc. (5.19%), Hookipa Pharma Inc (0.91%), Marinus Pharmaceuticals, Inc. (9.10%), LifeVantage Co. (0.78%), BioXcel Therapeutics, Inc. (4.00%), Tempest Therapeutics, Inc. (9.42%), Affimed (1.54%), Barinthus Biotherapeutics plc (0.05%), Chimerix, Inc. (1.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Connect Biopharma stock? Short selling CNTB is an investing strategy that aims to generate trading profit from Connect Biopharma as its price is falling. CNTB shares are trading up $0.49 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Connect Biopharma? A short squeeze for Connect Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTB, which in turn drives the price of the stock up even further. How often is Connect Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTB, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CRVS Short Interest JAGX Short Interest HOOK Short Interest MRNS Short Interest LFVN Short Interest BTAI Short Interest TPST Short Interest AFMD Short Interest BRNS Short Interest CMRX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTB) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAmerica’s worst nightmare?Porter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press